Thyroid Hormone Supplementation in Preterm Infants Born Before 28 Weeks Gestational Age and Neurodevelopmental Outcome at Age 36 Months
- 1 July 2014
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 24 (7) , 1162-1169
Abstract
Thyroid hormones are required for normal brain maturation, and neonatal plasma thyroid hormone concentrations are low in infants less than 28 weeks gestation. It is not known whether treatment of such infants with thyroid hormone improves neurodevelopmental outcome. At three years corrected age, mental, motor, and neurological development was assessed in infants born at less than 28 weeks gestational age who had participated in a phase 1 trial of differing doses and modes of administration of thyroid hormone. The trial's endpoints were thyroid hormone (thyroxine, T4) and thyotropin plasma concentrations in eight study arms: six treated with T4 [4, 8, and 16 μg/(kg · day)], bolus or continuous], one treated with iodine only, and one treated with placebo. Follow-up at three years was not part of the original study goals. Developmental index scores, rates of cerebral palsy (CP), and rates of adverse outcome (death or moderate to severe delay in development and/or disabling CP) were compared between the eight study groups and between groups combined by dosage level, and between infants with and without T4 supplementation. Of 166 randomized infants, 32 (19%) died in the neonatal period. Of the 134 survivors, follow-up results were available for 89 children (66%). Mental and motor development and rates of cerebral palsy did not differ in any of the comparisons made. In this study, no differences in neurodevelopment were found in relation to thyroid hormone treatment, but power was insufficient to detect any but very large differences.Keywords
This publication has 23 references indexed in Scilit:
- Delivery of maternal thyroid hormones to the fetusTrends in Endocrinology & Metabolism, 2011
- Thyroid hormones and fetal neurological developmentJournal of Endocrinology, 2011
- The measurement, definition, aetiology and clinical consequences of neonatal transient hypothyroxinaemiaAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2010
- Thyroid hormone action during brain development: More questions than answersMolecular and Cellular Endocrinology, 2010
- Thyroid System Immaturities in Very Low Birth Weight Premature InfantsSeminars in Perinatology, 2008
- Iodothyronine Levels in the Human Developing Brain: Major Regulatory Roles of Iodothyronine Deiodinases in Different AreasThe Journal of Clinical Endocrinology & Metabolism, 2004
- Fetal Tissues Are Exposed to Biologically Relevant Free Thyroxine Concentrations during Early Phases of DevelopmentThe Journal of Clinical Endocrinology & Metabolism, 2002
- Thyroid Function in Very Preterm Infants: Influences of Gestational Age and DiseasePediatric Research, 1997
- The Relation of Transient Hypothyroxinemia in Preterm Infants to Neurologic Development at Two Years of AgeNew England Journal of Medicine, 1996
- The Relation between Neonatal Thyroxine Levels and Neurodevelopmental Outcome at Age 5 and 9 Years in a National Cohort of Very Preterm and/or Very Low Birth Weight InfantsPediatric Research, 1996